Dance Biopharm Lands $9,500,000 New Financing

  • Feed Type
  • Date
    2/19/2015
  • Company Name
    Dance Biopharm
  • Mailing Address
    150 North Hill Drive Brisbane, CA 94005 USA
  • Company Description
    Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide. The company began operations in 2010 led by Dr. John Patton, who has over 20 years of experience in the development of inhaled insulin.
  • Website
    http://www.dancebiopharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The proceeds will be used to fund human clinical studies, manufacture drug and devices for clinical studies, and for working capital and general corporate purposes.
  • M&A Terms
  • Venture Investor

Trending on Xconomy